Supporting women's health outcomes after breast cancer treatment comparing a text message intervention to usual care: the EMPOWER-SMS randomised clinical trial.

ABSTRACT:

Purpose

The aim of this study is to evaluate the efficacy, feasibility and acceptability of a co-designed lifestyle-focused text message intervention (EMPOWER-SMS) for breast cancer survivors' self-efficacy, quality of life (QOL), mental (anxiety, depression, stress) and physical (endocrine therapy medication adherence, physical activity, BMI) health.

Methods

Single-blind randomised controlled trial (1:1) comparing EMPOWER-SMS to usual care at 6-months (intention-to-treat).

Setting

public Breast Cancer Institute (Sydney, Australia).

Eligibility criteria

adult (> 18 years) females, < 18-months post-active breast cancer treatment (stage I-III), owned a mobile phone, written informed consent.

Primary outcome

Self-Efficacy for Managing Chronic Disease Scale

SUBMITTER: Singleton AC 

PROVIDER: S-EPMC9034445 | biostudies-literature | 2023 Dec

REPOSITORIES: biostudies-literature